Technology

SIGA Technologies

$7.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-1.68%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SIGA and other stocks, options, and ETFs commission-free!

About SIGA

SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY. The listed name for SIGA is SIGA Technologies Inc. Common Stock.

CEO
Phillip Louis Gomez
Employees
41
Headquarters
New York, New York
Founded
1995
Market Cap
544.87M
Price-Earnings Ratio
17.38
Dividend Yield
—
Average Volume
202.41K
High Today
$7.19
Low Today
$6.99
Open Price
$7.08
Volume
325.06K
52 Week High
$8.10
52 Week Low
$3.96

Collections

SIGA Earnings

-$0.06
$0.06
$0.19
$0.31
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, After Hours

You May Also Like

SVXY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure